#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immune-mediated myositis Frostbite Immune-mediated renal disorder Neurofibromatosis Keratosis follicular Lymphatic malformation Osteochondrodysplasia Soft tissue sarcoma Thrombotic thrombocytopenic purpura Cardiac amyloidosis Congenital disorder of glycosylation Hydrocephalus Chorioretinitis Biliary neoplasm Rhabdomyosarcoma More trials…

    Learn about Rare Diseases

    Paraneoplastic neurological syndrome – Diagnostics Primary biliary cholangitis – Diagnostics Antithrombin III deficiency Toxic epidermal necrolysis – Trials in Disease Primary immunodeficiency syndrome – Trials in Disease Prolymphocytic leukaemia – Trials in Disease MELAS syndrome – Treatment Wiskott-Aldrich syndrome – Life with Disease Hereditary motor and sensory neuropathy – Life with Disease Mucopolysaccharidosis III – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cctx-001 Nortriptyline Dorzolamide HUMAN THROMBIN Specific Nucleic Acid Sna-Xfsb SALICYLIC ACID Vatiquinone Ecoo6A Vanglusagene Ensiparvovec Mianserin Hydrochloride Aavanc80-5'Hotof Octocog Alfa Methionine Vericiguat Temocillin Setmelanotide Histamine Hydrochloride Dabigatran Pegfilgrastim Ziftomenib More therapies…

    Learn about Your Condition

    Netherton's syndrome Tooth loss Inflammatory bowel disease Diabetic nephropathy Breast cancer metastatic Procedural anxiety Angina pectoris Joint stabilisation Bone marrow failure Anogenital warts Mucous membrane pemphigoid Wiskott-Aldrich syndrome Myxoid liposarcoma Aortic valve stenosis Muscle spasticity More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Arteriosclerosis

  • A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

    Not recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    • Chronic kidney disease
    Investigated Drugs:
    • Ziltivekimab
    Belgium Bulgaria Croatia Czechia Denmark Germany +12

  • Study on the Effect of Evolocumab on Heart Disease in Patients Needing Coronary Angiography

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Evolocumab
    France

  • Study on DFV890 and MAS825 for Reducing Inflammation in Adults with Coronary Heart Disease and Clonal Hematopoiesis

    Not recruiting

    2 1
    Investigated Drugs:
    • Dfv890
    • Human Igg1 Monoclonal Antibody Against Human Il-1 Beta And Human Il-18
    Germany

  • Study on the Safety and Effects of INZ-701 for Infants with ENPP1 or ABCC6 Deficiency

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency
    • Arteriosclerosis
    Investigated Drugs:
    • Recombinant Human Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Fused To The Fc Fragment Of Igg1
    Spain

  • Study on Reducing Lipoprotein Apheresis with Pelacarsen in Patients with High Lipoprotein(a) and Heart Disease in Germany

    Not recruiting

    3 1
    Investigated Drugs:
    • Pelacarsen
    Germany

  • Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Atorvastatin
    • Inclisiran
    • Rosuvastatin
    Austria Belgium Bulgaria Croatia Czechia Denmark +18
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!